Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
12
|
| pubmed:dateCreated |
1993-1-28
|
| pubmed:abstractText |
An isotopic exchange method was used to label lipiodol with 131I. The labelling efficiency was > 92.5%, and the radiochemical purity of [131I]lipiodol was above 98% as determined by ITLC. The influencing factors e.g. the heating temperature, reaction time, pH and storage conditions were studied and the optimum conditions were determined. In a pilot study injecting [131I]lipiodol for the treatment of hepatoma, about 70% of hepatoma patients had a response to the treatment with a reduction of alpha-fetoprotein and decrease of hepatoma sizes. The overall median survival was 9 months (range 2-17 months).
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Dec
|
| pubmed:issn |
0883-2889
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
43
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
1431-5
|
| pubmed:dateRevised |
2009-6-4
|
| pubmed:meshHeading |
pubmed-meshheading:1334953-Carcinoma, Hepatocellular,
pubmed-meshheading:1334953-Humans,
pubmed-meshheading:1334953-Iodine Radioisotopes,
pubmed-meshheading:1334953-Iodized Oil,
pubmed-meshheading:1334953-Isotope Labeling,
pubmed-meshheading:1334953-Liver Neoplasms,
pubmed-meshheading:1334953-Pilot Projects
|
| pubmed:year |
1992
|
| pubmed:articleTitle |
Preparation of [131I]lipiodol as a hepatoma therapeutic agent.
|
| pubmed:affiliation |
Institute of Nuclear Science, National Tsing Hua University, Hsinchu, Taiwan, Republic of China.
|
| pubmed:publicationType |
Journal Article
|